Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome

Epilepsia. 2013 Jul;54(7):1251-61. doi: 10.1111/epi.12213. Epub 2013 May 10.

Abstract

Purpose: Dravet syndrome (DS) is caused by dominant mutations of the SCN1A gene, encoding the NaV 1.1 sodium channel α subunit. Gene targeted mouse models of DS mutations replicate patients' phenotype and show reduced γ-aminobutyric acid (GABA)ergic inhibition. However, little is known on the properties of network hyperexcitability and on properties of seizure generation in these models. In fact, seizures have been studied thus far with surface electroencephalography (EEG), which did not show if specific brain regions are particularly involved. We have investigated hyperexcitability and epileptiform activities generated in neuronal networks of a mouse model of DS.

Methods: We have studied heterozygous NaV 1.1 knock-out mice performing field potential recordings in combined hippocampal/cortical slices in vitro and video/depth electrode intracerebral recordings in vivo during hyperthermia-induced seizures.

Key findings: In slices, we have disclosed specific signs of hyperexcitability of hippocampal circuits in both the pre-epileptic and epileptic periods, and a specific epileptiform activity was generated in the hippocampus upon application of the convulsant 4-aminopyridine in the epileptic period. During in vivo hyperthermia-induced seizures, we have observed selective hippocampal activity in early preictal phases and pronounced hippocampal activity in the ictal phase.

Significance: We have identified specific epileptiform activities and signs of network hyperexcitability, and disclosed the important role of the hippocampus in seizure generation in this model. These activities may be potentially used as targets for screenings of antiepileptic approaches.

Keywords: Epilepsy; GABAergic inhibition; Hyperexcitability; Severe myoclonic epilepsy of infancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / adverse effects
  • Age Factors
  • Animals
  • Animals, Newborn
  • Bicuculline / toxicity
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiopathology
  • Disease Models, Animal
  • Electric Stimulation / adverse effects
  • Electroencephalography
  • Epilepsies, Myoclonic / drug therapy
  • Epilepsies, Myoclonic / genetics
  • Epilepsies, Myoclonic / pathology*
  • Epilepsies, Myoclonic / physiopathology*
  • Excitatory Amino Acid Antagonists / pharmacology
  • GABA-A Receptor Antagonists / toxicity
  • Hippocampus / drug effects
  • Hippocampus / physiopathology*
  • Hyperthermia, Induced / adverse effects
  • In Vitro Techniques
  • Kynurenic Acid / pharmacology
  • Mice
  • Mice, Knockout
  • NAV1.1 Voltage-Gated Sodium Channel / deficiency
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • Potassium Channel Blockers / adverse effects
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / pathology
  • Pyramidal Cells / physiology

Substances

  • Excitatory Amino Acid Antagonists
  • GABA-A Receptor Antagonists
  • NAV1.1 Voltage-Gated Sodium Channel
  • Potassium Channel Blockers
  • Scn1a protein, mouse
  • 4-Aminopyridine
  • Kynurenic Acid
  • Bicuculline